Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1200studies shown
Showing 349-360 of 1,200
Other study type icon
RecruitingNCT06774417

Digital Strategies to Advance Help-Seeking - Aim 3

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.

In United States
SchizophreniaOtherFrom 12 Years to 29 Years
Countries
United States
Sponsor
Columbia University
Condition
Schizophrenia
Other study type icon
RecruitingNCT06774430

Digital Strategies to Advance Help-Seeking Aim 1 and 2

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.

In United States
SchizophreniaOtherFrom 12 Years to 29 Years
Countries
United States
Sponsor
Columbia University
Condition
Schizophrenia
Other study type icon
RecruitingNCT06066983

DINO RCT - Treating Anxiety in Children With Autism

This study is recruiting. It focuses on anxiety and currently lists participation information in the United States.

In United States
AnxietyOtherFrom 4 Years to 6 Years
Countries
United States
Sponsor
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Condition
Anxiety
Behavioral study icon
RecruitingNCT05560113

Disrupting Fear-based Memory Consolidation

This study is recruiting. It focuses on PTSD and currently lists participation information in the United States.

In United States
PTSDBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Emory University
Condition
PTSD
Drug study icon
RecruitingISRCTN61794329

Does oral N-acetyl-cysteine (NAC) improve schizophrenia symptoms?

This study is recruiting. It focuses on schizophrenia and currently lists participation information in Switzerland and the United States.

In United States
SchizophreniaOther
Countries
United States, Switzerland
Sponsor
Swiss National Science Foundation (Fonds National Suisse de la Recherche Scientifique [SNSF]) (Switzerland)
Condition
Schizophrenia
Drug study icon
RecruitingNCT06075771

Dopaminergic Therapy for Anhedonia - 2

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

In United States
DepressionDrugA study involving a medication or substance.From 25 Years to 55 Years
Countries
United States
Sponsor
Emory University
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.

United States | Clinical Trials | HopeStage Research